IL-17 receptor antibody formulation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8883151
SERIAL NO

13521999

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to AM-14 pharmaceutical formulations and therapeutic dosing regimens for the treatment of disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AMGEN K-A INCONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baumgartner, Scott Walter Cardiff by the Sea, US 5 26
Endres, Christopher J Seattle, US 1 22
Huang, Holly Zhuohong Thousand Oaks, US 6 48
Liu, Dingjiang Oak Park, US 26 97
Martin, David Andrew Seattle, US 7 89
Russell, Christopher Boyd Bainbridge Island, US 5 26
Salinger, David H Seattle, US 5 26

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 11, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00